Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075654 | SCV001241281 | likely pathogenic | Retinal dystrophy | 2019-03-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001382260 | SCV001580940 | pathogenic | not provided | 2023-10-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1652*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is present in population databases (no rsID available, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with EYS-related conditions (PMID: 28559085, 29159838). ClinVar contains an entry for this variant (Variation ID: 867110). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003462634 | SCV004192885 | pathogenic | Retinitis pigmentosa 25 | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003462634 | SCV005670598 | likely pathogenic | Retinitis pigmentosa 25 | 2024-03-12 | criteria provided, single submitter | clinical testing |